Free Trial

Fresenius Medical Care (FMS) Competitors

Fresenius Medical Care logo
$23.08 +0.15 (+0.63%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$23.05 -0.04 (-0.15%)
As of 02/21/2025 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FMS vs. NTRA, HIMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, and LFST

Should you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include Natera (NTRA), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

Fresenius Medical Care vs.

Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natera$1.08B19.79-$434.80M-$1.76-92.22
Fresenius Medical Care$21.05B0.64$540.07M$1.2119.08

Natera received 61 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 69.04% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
NateraOutperform Votes
484
69.04%
Underperform Votes
217
30.96%
Fresenius Medical CareOutperform Votes
423
54.72%
Underperform Votes
350
45.28%

In the previous week, Natera had 10 more articles in the media than Fresenius Medical Care. MarketBeat recorded 13 mentions for Natera and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.56 beat Natera's score of 1.35 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natera
10 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Natera-14.01% -26.23% -14.27%
Fresenius Medical Care 3.43%6.04%2.69%

Natera currently has a consensus price target of $170.94, suggesting a potential upside of 5.32%. Fresenius Medical Care has a consensus price target of $25.30, suggesting a potential upside of 9.59%. Given Fresenius Medical Care's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than Natera.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natera
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
3.00
Fresenius Medical Care
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Natera has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500.

Summary

Natera and Fresenius Medical Care tied by winning 9 of the 18 factors compared between the two stocks.

Get Fresenius Medical Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

MetricFresenius Medical Carehealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$13.55B$1.94B$5.77B$20.08B
Dividend Yield1.91%7.61%4.78%3.65%
P/E Ratio19.0816.6825.8234.36
Price / Sales0.646.99453.6615.65
Price / Cash5.029.3044.0520.85
Price / Book0.844.547.634.92
Net Income$540.07M$87.49M$3.18B$1.02B
7 Day Performance-1.58%-2.59%-1.95%-1.05%
1 Month Performance-0.41%-6.14%-0.23%-1.09%
1 Year Performance18.05%-23.95%16.69%13.70%

Fresenius Medical Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care
3.9964 of 5 stars
$23.09
+0.6%
$25.30
+9.6%
+19.5%$13.55B$21.05B19.081,358Positive News
High Trading Volume
NTRA
Natera
2.5827 of 5 stars
$173.39
+1.6%
$165.88
-4.3%
+132.7%$22.89B$1.08B-98.523,293Positive News
HIMS
Hims & Hers Health
2.645 of 5 stars
$60.41
+2.1%
$25.13
-58.4%
+422.3%$13.20B$872M137.311,046Analyst Downgrade
Insider Trade
News Coverage
Gap Down
High Trading Volume
GH
Guardant Health
4.2446 of 5 stars
$48.12
+2.4%
$42.63
-11.4%
+89.2%$5.95B$563.95M-11.351,779Earnings Report
Analyst Forecast
News Coverage
Gap Up
OPCH
Option Care Health
4.0316 of 5 stars
$31.46
-1.1%
$32.25
+2.5%
-4.1%$5.35B$4.30B26.447,802Positive News
RDNT
RadNet
3.9241 of 5 stars
$61.33
-1.9%
$75.50
+23.1%
+54.4%$4.54B$1.62B-876.0210,288Positive News
BTSG
BrightSpring Health Services
1.8058 of 5 stars
$22.05
-0.1%
$19.42
-11.9%
+93.7%$3.84B$10.59B-84.8135,000
SHC
Sotera Health
2.1641 of 5 stars
$13.48
+0.4%
$16.08
+19.3%
-17.6%$3.82B$1.05B53.923,000Analyst Forecast
News Coverage
Negative News
SGRY
Surgery Partners
3.0863 of 5 stars
$25.87
+0.3%
$36.56
+41.3%
-23.0%$3.29B$2.74B-53.9013,500
VCYT
Veracyte
2.9128 of 5 stars
$41.11
+3.8%
$42.00
+2.2%
+59.7%$3.19B$361.05M-274.07790Analyst Downgrade
News Coverage
LFST
LifeStance Health Group
1.5412 of 5 stars
$7.97
-0.3%
$8.70
+9.2%
+22.0%$3.05B$1.21B-30.659,325Upcoming Earnings
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:FMS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners